Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: From 10-K--preferred stock (Note in bold)

10-K 2009:

We May Issue Preferred Stock, And The Terms Of Such Preferred Stock May Reduce The Value Of Our Common Stock.


We are authorized to issue up to a total of 5,000,000 shares of preferred stock in one or more series. Our Board of Directors may determine whether to issue shares of preferred stock without further action by holders of our Common Stock. If we issue additional shares of preferred stock, it could affect the rights or reduce the value of our Common Stock. In particular, specific rights granted to future holders of preferred stock could be used to restrict our ability to merge with or sell our assets to a third party. These terms may include voting rights, preferences as to dividends and liquidation, conversion and redemption rights, and sinking fund provisions. We continue to seek capital for our business, and this additional capital may be raised through the issuance of additional preferred stock.
.
.
.
.
Be well
9
Aug 19, 2010 01:57PM
9
Aug 19, 2010 03:05PM
6
Aug 19, 2010 03:50PM
3
Aug 19, 2010 04:11PM
11
Aug 19, 2010 04:49PM
8
Aug 19, 2010 05:00PM
3
Aug 19, 2010 05:05PM
6
Aug 19, 2010 05:08PM
6
Aug 19, 2010 05:19PM
6
Aug 19, 2010 05:36PM
3
Aug 19, 2010 05:41PM
7
Aug 19, 2010 05:46PM
25
Aug 19, 2010 10:14PM
9
Aug 20, 2010 09:07AM
12
Aug 20, 2010 09:39AM
6
Aug 20, 2010 09:44AM
9
Aug 20, 2010 09:56AM
11
Aug 20, 2010 11:16AM
7
Aug 20, 2010 11:21AM
17
Aug 20, 2010 11:35AM
9
Aug 20, 2010 11:38AM
7
Aug 20, 2010 11:45AM
7
Aug 20, 2010 11:49AM
10
Aug 20, 2010 12:01PM
6
Aug 20, 2010 12:41PM
11
Aug 20, 2010 12:55PM
8
Aug 20, 2010 01:06PM
3
Aug 20, 2010 01:11PM
9
Aug 20, 2010 01:51PM
15
Aug 20, 2010 02:42PM
11
Aug 20, 2010 03:44PM
Share
New Message
Please login to post a reply